(R)-4-[3-(3-isopropylphenoxy)pyrrolidin-1-yl]-6,7-dimethoxyquinazoline

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 二氮杂萘
• 英文名称: (R)-4-[3-(3-isopropylphenoxy)pyrrolidin-1-yl]-6,7-dimethoxyquinazoline
• 英文别名: (R)-4-[3-(3-isopropyl-phenoxy)-pyrrolidin-1-yl]-6,7-dimethoxy-quinazoline；6,7-dimethoxy-4-[(3R)-3-(3-propan-2-ylphenoxy)pyrrolidin-1-yl]quinazoline
• 化学式: C₂₃H₂₇N₃O₃
• 分子量: 393.486
• InChiKey: PKPONRIRXFIKES-GOSISDBHSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  4.9
• 重原子数：
  29
• 可旋转键数：
  6
• 环数：
  4.0
• sp3杂化的碳原子比例：
  0.39
• 拓扑面积：
  56.7
• 氢给体数：
  0
• 氢受体数：
  6

反应信息

• 作为产物：
  描述：

  3-异丙基苯酚 在 potassium carbonate 、 三苯基膦 、 三氟乙酸 、 偶氮二甲酸二乙酯 作用下， 以 四氢呋喃 、 二氯甲烷 、 甲苯 为溶剂， 反应 21.0h， 生成 (R)-4-[3-(3-isopropylphenoxy)pyrrolidin-1-yl]-6,7-dimethoxyquinazoline
  参考文献：
  名称：

  Discovery of a Series of 6,7-Dimethoxy-4-pyrrolidylquinazoline PDE10A Inhibitors

  摘要：

  A papaverine based pharmacophore model for PDE10A inhibition was generated via SBDD and used to design a library of 4-amino-6,7-dimethoxyquinazolines. From this library emerged an aryl ether pyrrolidyl 6,7-dimethoxyquinazoline series that became the focal point for additional modeling, X-ray, and synthetic efforts toward increasing PDE10A inhibitory potency and selectivity versus PDE3A/B. These efforts culminated in the discovery of 29, a potent and selective brain penetrable inhibitor of PDE10A.

  DOI：

  10.1021/jm060653b

文献信息

• Discovery of a Series of 6,7-Dimethoxy-4-pyrrolidylquinazoline PDE10A Inhibitors
  作者：Thomas A. Chappie、John M. Humphrey、Martin P. Allen、Kimberly G. Estep、Carol B. Fox、Lorraine A. Lebel、Spiros Liras、Eric S. Marr、Frank S. Menniti、Jayvardhan Pandit、Christopher J. Schmidt、Meihua Tu、Robert D. Williams、Feng V. Yang

  DOI：10.1021/jm060653b

  日期：2007.1.1

  A papaverine based pharmacophore model for PDE10A inhibition was generated via SBDD and used to design a library of 4-amino-6,7-dimethoxyquinazolines. From this library emerged an aryl ether pyrrolidyl 6,7-dimethoxyquinazoline series that became the focal point for additional modeling, X-ray, and synthetic efforts toward increasing PDE10A inhibitory potency and selectivity versus PDE3A/B. These efforts culminated in the discovery of 29, a potent and selective brain penetrable inhibitor of PDE10A.